Navigation Links
GORE-TEX® Vascular Grafts

ProductsGORE-TEX® Vascular Grafts
Company W. L. Gore & Associates, Inc.
Item GORE-TEX® Vascular Grafts
Features 
  • Superior graft performance.
  • Inert.
  • Biocompatible.
  • Strong.
  • Conformable.
  • Easy-to-handle.
  • Description GORE-TEX® Vascular Grafts have met the challenges of the most demanding vascular procedures for over 25 years. Recognized for exceptional performance and quality, they have earned the endorsement of renowned surgeons worldwide. These grafts require no preclotting, resist dilatation and the spread of infection, and assure utmost thrombectomy safety. Gore vascular grafts are also available in a wide range of Stretch, and non-stretch configurations, including straight, tapered, bifurcated, and many with external customizable ring reinforcement.
    Info W. L. Gore & Associates, Inc.
    Customer Service: (800) 437-8181

    Related medicine products :

    1. GORE-TEX® INTERING Vascular Graft-Standard Walled
    2. GORE-TEX® Stretch Vascular Grafts-Standard Wall with Removable Rings
    3. Vascular Clamps B-1
    4. Vascular Clamps B-2
    5. Vascular Clamps B-3
    6. Vascular Clamps HD-S
    7. Vascular Clamps RD-S
    8. Vascular Clamps ABB-11
    9. Vasoguard Vascular Doppler
    10. VersaLab Vascular Doppler
    11. Vasoguard Microlite Vascular Doppler
    ... pessary is designed for third ... well as a cystocele and ... available both with and without ... silicone tie to aid in ...
    The Incontinence Dish is used to relieve stress incontinence and minor degrees of prolapse. The Incontinence Dish comes with and without support. It is available in eight different sizes....
    The Shaatz pessary, available in nine sizes, is used for a first to second degree prolapse and an accompanying cystocele....
    ... ABP Systems are among the ... market today, with advanced reporting ... of patient information. Extensive testing ... Burdick ABPM accuracy, making it ...
    Medicine Products:
    (Date:1/19/2017)... ... 19, 2017 , ... Attorney Robert “RC” Pate , founder of The ... the Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric ... firsthand the effect of the critical funding gap for research into pediatric cancer research. ...
    (Date:1/19/2017)... ... ... Connecticut Dermatology Group (CDG) is proud and excited to welcome back to the ... brings an extensive background in cutting-edge dermatology care and research to Connecticut’s largest ... Kim to the CDG team” said President and Managing Partner Dr. Steven A. Kolenik ...
    (Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons from ... in breast surgery. Covering topics from cosmetic breast augmentation to breast ...
    (Date:1/18/2017)... ... ... From a health perspective, 2017 will clearly be the Year of the Gut. ... health and general physical well-being. The New York Times suggested a “ Gut Makeover ... Charlottesville restaurant, good gut health is clearly on the menu. Threepenny Cafe ...
    (Date:1/18/2017)... ... January 18, 2017 , ... The V Foundation for ... V, its official endurance training and fundraising team, to compete in the Boston Marathon ... those inspired to finish the world’s oldest annual marathon to join Team V and ...
    Breaking Medicine News(10 mins):
    (Date:1/18/2017)... PHILADELPHIA , Jan. 18, 2017 The Philadelphia ... three companies developing medical devices for children. The Consortium ... to receive seed grants of $50,000 each. The ... amplifies weak nerve signals, a hand-operated rapid blood delivery system ... ears in babies. ...
    (Date:1/18/2017)... , Jan. 18, 2017   Regenicin, Inc. ... biotechnology company specializing in the development and commercialization of ... tissues and organs, recently reported the Company,s operating results ... 2017. As the Company described in its ... a year of substantial accomplishments. The Company,s contract laboratory ...
    (Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
    Breaking Medicine Technology: